@speakup
Kick off Friday w good news
F%%k cancer.
-
The once-daily pill, to be called Rasonque, was approved for metastatic ‌pancreatic cancer in patients who have received prior treatment or cannot receive combination chemotherapy. The drug is designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.
Revolution said the drug is now available in the U.S. at ​a price of $39,800 for a 30-day supply, with eligible commercially insured patients potentially paying as little as $0 with co-pay assistance.
https://www.cnn.com/2026/08/26/health/daraxonrasib-pancreatic-cancer-fda
1 reply
0 recast
9 reactions